Review




Structured Review

Merck & Co lentivirus expressing shrna constructs
A RNAi screen for the identification of functional regulator of radiation-induced cell plasticity. A . schematic representation of RNAi screening strategy. B-C . Proportion of ALDH br cells in BFP + ( B ) and RFP + SUM159 cells ( C ) following silencing of each individual gene contained in the RNAi library and normalized with non-targeting <t>siRNA</t> (siCTRL). Genes targeted by a siRNA inducing a significant reduction of the ALDH br cell proportion are highlighted. Statistical test used is Student's t-test. Data represent mean ± SD D . Representative images of the high-content screening captures. ALDEFLUOR cellular staining is represented in green. Dead cells are labeled by DRAQ5 in red. RFP+ cells are in yellow and BFP+ cells in blue. E-F . Validation of candidate genes using FACS analysis. Proportion of ALDH br cells in BFP + ( E ) and RFP + SUM159 cells ( F ) are represented normalized with non-targeting siRNA (siCTRL). siRNA targeting ALDH1A1 was used as positive control and siRNA targeting TEXT12 or VDACL were used as negative control. Statistical test used is Student's t-test. Data represent mean ± SD. *p<0.05, **p<0.01, ***p<0.001.
Lentivirus Expressing Shrna Constructs, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shrna+construct+shctrl/expressing+hairpin+lentiviral+mission+particles+rna+short+shrna+shrna+sirt3+targeting+transduction+trc/pmc12325171-221-19-30
Average 86 stars, based on 1 article reviews
lentivirus expressing shrna constructs - by Bioz Stars, 2026-10
86/100 stars

Images

1) Product Images from "The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer"

Article Title: The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer

Journal: Theranostics

doi: 10.7150/thno.101393

A RNAi screen for the identification of functional regulator of radiation-induced cell plasticity. A . schematic representation of RNAi screening strategy. B-C . Proportion of ALDH br cells in BFP + ( B ) and RFP + SUM159 cells ( C ) following silencing of each individual gene contained in the RNAi library and normalized with non-targeting siRNA (siCTRL). Genes targeted by a siRNA inducing a significant reduction of the ALDH br cell proportion are highlighted. Statistical test used is Student's t-test. Data represent mean ± SD D . Representative images of the high-content screening captures. ALDEFLUOR cellular staining is represented in green. Dead cells are labeled by DRAQ5 in red. RFP+ cells are in yellow and BFP+ cells in blue. E-F . Validation of candidate genes using FACS analysis. Proportion of ALDH br cells in BFP + ( E ) and RFP + SUM159 cells ( F ) are represented normalized with non-targeting siRNA (siCTRL). siRNA targeting ALDH1A1 was used as positive control and siRNA targeting TEXT12 or VDACL were used as negative control. Statistical test used is Student's t-test. Data represent mean ± SD. *p<0.05, **p<0.01, ***p<0.001.
Figure Legend Snippet: A RNAi screen for the identification of functional regulator of radiation-induced cell plasticity. A . schematic representation of RNAi screening strategy. B-C . Proportion of ALDH br cells in BFP + ( B ) and RFP + SUM159 cells ( C ) following silencing of each individual gene contained in the RNAi library and normalized with non-targeting siRNA (siCTRL). Genes targeted by a siRNA inducing a significant reduction of the ALDH br cell proportion are highlighted. Statistical test used is Student's t-test. Data represent mean ± SD D . Representative images of the high-content screening captures. ALDEFLUOR cellular staining is represented in green. Dead cells are labeled by DRAQ5 in red. RFP+ cells are in yellow and BFP+ cells in blue. E-F . Validation of candidate genes using FACS analysis. Proportion of ALDH br cells in BFP + ( E ) and RFP + SUM159 cells ( F ) are represented normalized with non-targeting siRNA (siCTRL). siRNA targeting ALDH1A1 was used as positive control and siRNA targeting TEXT12 or VDACL were used as negative control. Statistical test used is Student's t-test. Data represent mean ± SD. *p<0.05, **p<0.01, ***p<0.001.

Techniques Used: Functional Assay, High Content Screening, Staining, Labeling, Biomarker Discovery, Positive Control, Negative Control

LRP4/YAP axis inhibition radiosensitizes iCSC. A-B . Proportion of cells ( A , SUM159; B , S68) presenting a nuclear location of YAP in each cell subpopulations five days post-irradiation, with representative images of YAP staining (in green) in each cell subpopulations on the right panel. Nuclei are counterstained with DAPi (in blue). C . Pre-ranked GSEA interrogating differential expression between iCSC and late non-CSC and YAP/TAZ target genes. D . Western blot of markers related to YAP/TAZ signaling and its activation in SUM159 and S68 cells silenced for LRP4 (shLRP4) compared to the non-targeting shRNA (shCTRL). The mean intensities are indicated below each band for each condition. E . Heat map representing the mRNA expression of the LRP4, ALDH1A1, and YAP/TAZ target genes in SUM159 and S68 silenced for LRP4 (siLRP4) compared to the non-targeting siRNA (siCTRL). Each row represents three independent replicates per conditions (R1, R2, and R3). F . Proportion of SUM159 cells presenting a nuclear location of YAP in late non-CSC and iCSC following LRP4 silencing (siLRP4) compared to a non-targeting siRNA (siCTRL). G-H . SUM159 ( G ) and S68 cells ( H ), following LRP4 silencing (shLRP4) compared to a non-targeting siRNA (shCTRL), were exposed to various dose of radiation therapy and subjected to clonogenic survival assays ( G ), with representative images (right panels). I . Patient-derived xenograft organoid (PDXO) size distribution for CRCM389 cells WT (shCTRL) or silenced for LRP4 (shLRP4) following irradiation (RT) and compared to untreated condition (CTRL) (left panel). Representative pictures of PDXO-CRCM389 7 days post-treatment (right panel). Statistical test used is Student's t-test. Data represent mean ± SD. ns (not significant), *p<0.05, **p<0.01, ***p<0.001. J . Kaplan-Meier tumor-free survival curves of mice xenografted with 100,000-200,000 SUM159 irradiated cells silenced for LRP4 (shLRP4) compared to the control (shCTRL). p-value and hazard ration (HR) estimated according to Log-rank (Mantel-Cox) test.
Figure Legend Snippet: LRP4/YAP axis inhibition radiosensitizes iCSC. A-B . Proportion of cells ( A , SUM159; B , S68) presenting a nuclear location of YAP in each cell subpopulations five days post-irradiation, with representative images of YAP staining (in green) in each cell subpopulations on the right panel. Nuclei are counterstained with DAPi (in blue). C . Pre-ranked GSEA interrogating differential expression between iCSC and late non-CSC and YAP/TAZ target genes. D . Western blot of markers related to YAP/TAZ signaling and its activation in SUM159 and S68 cells silenced for LRP4 (shLRP4) compared to the non-targeting shRNA (shCTRL). The mean intensities are indicated below each band for each condition. E . Heat map representing the mRNA expression of the LRP4, ALDH1A1, and YAP/TAZ target genes in SUM159 and S68 silenced for LRP4 (siLRP4) compared to the non-targeting siRNA (siCTRL). Each row represents three independent replicates per conditions (R1, R2, and R3). F . Proportion of SUM159 cells presenting a nuclear location of YAP in late non-CSC and iCSC following LRP4 silencing (siLRP4) compared to a non-targeting siRNA (siCTRL). G-H . SUM159 ( G ) and S68 cells ( H ), following LRP4 silencing (shLRP4) compared to a non-targeting siRNA (shCTRL), were exposed to various dose of radiation therapy and subjected to clonogenic survival assays ( G ), with representative images (right panels). I . Patient-derived xenograft organoid (PDXO) size distribution for CRCM389 cells WT (shCTRL) or silenced for LRP4 (shLRP4) following irradiation (RT) and compared to untreated condition (CTRL) (left panel). Representative pictures of PDXO-CRCM389 7 days post-treatment (right panel). Statistical test used is Student's t-test. Data represent mean ± SD. ns (not significant), *p<0.05, **p<0.01, ***p<0.001. J . Kaplan-Meier tumor-free survival curves of mice xenografted with 100,000-200,000 SUM159 irradiated cells silenced for LRP4 (shLRP4) compared to the control (shCTRL). p-value and hazard ration (HR) estimated according to Log-rank (Mantel-Cox) test.

Techniques Used: Inhibition, Irradiation, Staining, Quantitative Proteomics, Western Blot, Activation Assay, shRNA, Expressing, Derivative Assay, Control

Related Articles

Generated:

Article Title: Filopodia-mediated trans-endocytosis
Article Snippet: HUVECs were electroporated using the Neon Transfection System (ThermoFisher Scientific, MPK5000) with the 10 μL kit (MPK1025; Thermo Fisher Scientific) following the manufacturer’s instructions (150,000 cells and 1 μg plasmid DNA per transfection) and as previously described ( ). .. The DCIS.com lifeact-RFP shCTRL and shMYO10 lines were generated previously ( ) using lentiviral particles containing a non-target control shRNA (Merck, Cat Number: SHC016V-1EA) or shRNA targeting human MYO10 (shMYO10 3, TRCN0000123087; shMYO10 4, TRCN0000123088), respectively. .. DCIS.com and U-2 OS cells were transfected with the indicated plasmids using Lipofectamine 3000 and the P3000 Enhancer Reagent (Thermo Fisher Scientific, L3000001) according to the manufacturer’s instructions.

Control:

Article Title: Filopodia-mediated trans-endocytosis
Article Snippet: HUVECs were electroporated using the Neon Transfection System (ThermoFisher Scientific, MPK5000) with the 10 μL kit (MPK1025; Thermo Fisher Scientific) following the manufacturer’s instructions (150,000 cells and 1 μg plasmid DNA per transfection) and as previously described ( ). .. The DCIS.com lifeact-RFP shCTRL and shMYO10 lines were generated previously ( ) using lentiviral particles containing a non-target control shRNA (Merck, Cat Number: SHC016V-1EA) or shRNA targeting human MYO10 (shMYO10 3, TRCN0000123087; shMYO10 4, TRCN0000123088), respectively. .. DCIS.com and U-2 OS cells were transfected with the indicated plasmids using Lipofectamine 3000 and the P3000 Enhancer Reagent (Thermo Fisher Scientific, L3000001) according to the manufacturer’s instructions.

Article Title: Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers
Article Snippet: FANCA shRNA knockdown (KD) was performed in RPE1 hTERT p53 -/- cells using two FANCA -targeting shRNAs (TRCN0000296799 and TRCN0000291182, Merck). .. Additionally, one non-targeting control shRNA (MISSION TRC2 pLKO.5-puro, Merck) was used. ..

Article Title: Heme oxygenase-1 emerges as a critical regulator linking autophagy dysregulation, immune infiltration, and NOD-Like receptor signaling in PCOS pathogenesis.
Article Snippet: Polycystic ovary syndrome (PCOS) is a prevalent endocrine-metabolic disorder affecting approximately 6–10% of women of reproductive age [1].. It is primarily characterized by hyperandrogenism, chronic anovulation, and polycystic ovarian morphology, all of which contribute to female infertility due to anovulation and hyperandrogenism [2].. Additionally, most PCOS patients develop peripheral insulin resistance (IR), increasing the risk of type 2 diabetes (DM2).

shRNA:

Article Title: Filopodia-mediated trans-endocytosis
Article Snippet: HUVECs were electroporated using the Neon Transfection System (ThermoFisher Scientific, MPK5000) with the 10 μL kit (MPK1025; Thermo Fisher Scientific) following the manufacturer’s instructions (150,000 cells and 1 μg plasmid DNA per transfection) and as previously described ( ). .. The DCIS.com lifeact-RFP shCTRL and shMYO10 lines were generated previously ( ) using lentiviral particles containing a non-target control shRNA (Merck, Cat Number: SHC016V-1EA) or shRNA targeting human MYO10 (shMYO10 3, TRCN0000123087; shMYO10 4, TRCN0000123088), respectively. .. DCIS.com and U-2 OS cells were transfected with the indicated plasmids using Lipofectamine 3000 and the P3000 Enhancer Reagent (Thermo Fisher Scientific, L3000001) according to the manufacturer’s instructions.

Article Title: Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers
Article Snippet: FANCA shRNA knockdown (KD) was performed in RPE1 hTERT p53 -/- cells using two FANCA -targeting shRNAs (TRCN0000296799 and TRCN0000291182, Merck). .. Additionally, one non-targeting control shRNA (MISSION TRC2 pLKO.5-puro, Merck) was used. ..

Article Title: Heme oxygenase-1 emerges as a critical regulator linking autophagy dysregulation, immune infiltration, and NOD-Like receptor signaling in PCOS pathogenesis.
Article Snippet: Polycystic ovary syndrome (PCOS) is a prevalent endocrine-metabolic disorder affecting approximately 6–10% of women of reproductive age [1].. It is primarily characterized by hyperandrogenism, chronic anovulation, and polycystic ovarian morphology, all of which contribute to female infertility due to anovulation and hyperandrogenism [2].. Additionally, most PCOS patients develop peripheral insulin resistance (IR), increasing the risk of type 2 diabetes (DM2).

other:

Article Title: Spatiotemporal regulation of energetic charge dictates T cell function
Article Snippet: T cells were activated in plates coated with anti-CD3 monoclonal antibody (mAb) (2.5 μg ml−1; clone 17.A2; BioLegend) in the presence of soluble anti-CD28 mAb (2.5 μg ml−1; clone 37.51; BioLegend) and murine IL-12 (10 ng ml−1; I8523; Sigma-Aldrich) .

Article Title: Spatiotemporal regulation of energetic charge dictates T cell function.
Article Snippet: Generation of T cells expressing the glucose reporter iGluco The construct of encoding the iGlucoSnFR-mRuby2 (iGluco) glucose probe17 was obtained from Addgene and subcloned into the retroviral vector MSCV.

Incubation:

Article Title: SARS-CoV-2 nonspike structural proteins hijack mucosa epithelial cell fate.
Article Snippet: .. For full thickness 3D equivalents, samples were incubated with 200 μl lentiviral particles with 10 μg/ml polybrene (Merck) at day 14 day after airlifting. ..

Article Title: SARS-CoV-2 nonspike structural proteins hijack mucosa epithelial cell fate
Article Snippet: .. For full thickness 3D equivalents, samples were incubated with 200 μl lentiviral particles with 10 μg/ml polybrene (Merck) at day 14 day after airlifting. ..



Similar Products

96
OriGene shctrl constructs
Shctrl Constructs, supplied by OriGene, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shrna+construct+shctrl/Scrambled+shRNA+control+in+pGFP-C-shLenti+shRNA+Vector/pm38873940-270-3-8
Average 96 stars, based on 1 article reviews
shctrl constructs - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

90
Millipore thenontargeting (shctrl) shrna construct (shc002)
Thenontargeting (Shctrl) Shrna Construct (Shc002), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shrna+construct+shctrl/non+targeting+shrna/10__1158_slash_0008___5472__can___21___1114-60-0-6
Average 90 stars, based on 1 article reviews
thenontargeting (shctrl) shrna construct (shc002) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Thermo Fisher shrna construct shctrl
Silencing of integrin a6 in MES-GSCs does not have an impact on stemness and self-renewal. ( A , C ) Representative Western blot of the lentiviral-based <t>shRNA</t> silencing of ITGA6 in PN-GIC2 ( A ) and MES-GSCs ( C ). The values indicated within blots are relative to the densitometric analysis. Numbers indicate the normalized integrin a6 intensity ratio relative to the mean of <t>normalized</t> <t>shCTRL</t> samples. ( B ) Assessment of self-renewal capacity (mean ± SEM; n = 3; unpaired t -test) and sphere size (mean ± SEM; n = 3; Mann–Whitney test) in PN-GSCs silenced for ITGA6 . Micrographs from representative fields of gliomaspheres (scale bar = 100 µm). ( D ) Self-renewal capacity (mean ± SEM; n = 4; unpaired t -test) and sphere size (mean ± SEM; n = 4; Mann–Whitney test) in MES-GSCs silenced for ITGA6 . The number of independent experiments— n , the number of gliomaspheres scored for each condition—N. The values specified within the bar plot indicate the mean relative self-renewal capacity. ( E ) Transcript levels of ITGA6 and NES detected by means of qPCR in shITGA6 PN-GSCs and MES-GSCs (mean ± SEM; n = 3; unpaired t -test). ( F ) Relative transcript amount of ALDH1A3 , a specific MES stem cell marker, in shITGA6 MES-GSCs (mean ± SEM; n = 3; unpaired t -test). *** p < 0.001; **** p < 0.0001.
Shrna Construct Shctrl, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shrna+construct+shctrl/lentiviral+shrna+pgipz+vectors+ns+rhs4348/pmc08235627-77-1-26
Average 90 stars, based on 1 article reviews
shrna construct shctrl - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Millipore shctrl shrna construct (shc002)
Silencing of integrin a6 in MES-GSCs does not have an impact on stemness and self-renewal. ( A , C ) Representative Western blot of the lentiviral-based <t>shRNA</t> silencing of ITGA6 in PN-GIC2 ( A ) and MES-GSCs ( C ). The values indicated within blots are relative to the densitometric analysis. Numbers indicate the normalized integrin a6 intensity ratio relative to the mean of <t>normalized</t> <t>shCTRL</t> samples. ( B ) Assessment of self-renewal capacity (mean ± SEM; n = 3; unpaired t -test) and sphere size (mean ± SEM; n = 3; Mann–Whitney test) in PN-GSCs silenced for ITGA6 . Micrographs from representative fields of gliomaspheres (scale bar = 100 µm). ( D ) Self-renewal capacity (mean ± SEM; n = 4; unpaired t -test) and sphere size (mean ± SEM; n = 4; Mann–Whitney test) in MES-GSCs silenced for ITGA6 . The number of independent experiments— n , the number of gliomaspheres scored for each condition—N. The values specified within the bar plot indicate the mean relative self-renewal capacity. ( E ) Transcript levels of ITGA6 and NES detected by means of qPCR in shITGA6 PN-GSCs and MES-GSCs (mean ± SEM; n = 3; unpaired t -test). ( F ) Relative transcript amount of ALDH1A3 , a specific MES stem cell marker, in shITGA6 MES-GSCs (mean ± SEM; n = 3; unpaired t -test). *** p < 0.001; **** p < 0.0001.
Shctrl Shrna Construct (Shc002), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shrna+construct+shctrl/non+targeting+shrna/us10308698-333-1-9
Average 90 stars, based on 1 article reviews
shctrl shrna construct (shc002) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Silencing of integrin a6 in MES-GSCs does not have an impact on stemness and self-renewal. ( A , C ) Representative Western blot of the lentiviral-based shRNA silencing of ITGA6 in PN-GIC2 ( A ) and MES-GSCs ( C ). The values indicated within blots are relative to the densitometric analysis. Numbers indicate the normalized integrin a6 intensity ratio relative to the mean of normalized shCTRL samples. ( B ) Assessment of self-renewal capacity (mean ± SEM; n = 3; unpaired t -test) and sphere size (mean ± SEM; n = 3; Mann–Whitney test) in PN-GSCs silenced for ITGA6 . Micrographs from representative fields of gliomaspheres (scale bar = 100 µm). ( D ) Self-renewal capacity (mean ± SEM; n = 4; unpaired t -test) and sphere size (mean ± SEM; n = 4; Mann–Whitney test) in MES-GSCs silenced for ITGA6 . The number of independent experiments— n , the number of gliomaspheres scored for each condition—N. The values specified within the bar plot indicate the mean relative self-renewal capacity. ( E ) Transcript levels of ITGA6 and NES detected by means of qPCR in shITGA6 PN-GSCs and MES-GSCs (mean ± SEM; n = 3; unpaired t -test). ( F ) Relative transcript amount of ALDH1A3 , a specific MES stem cell marker, in shITGA6 MES-GSCs (mean ± SEM; n = 3; unpaired t -test). *** p < 0.001; **** p < 0.0001.

Journal: Cancers

Article Title: Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells

doi: 10.3390/cancers13123055

Figure Lengend Snippet: Silencing of integrin a6 in MES-GSCs does not have an impact on stemness and self-renewal. ( A , C ) Representative Western blot of the lentiviral-based shRNA silencing of ITGA6 in PN-GIC2 ( A ) and MES-GSCs ( C ). The values indicated within blots are relative to the densitometric analysis. Numbers indicate the normalized integrin a6 intensity ratio relative to the mean of normalized shCTRL samples. ( B ) Assessment of self-renewal capacity (mean ± SEM; n = 3; unpaired t -test) and sphere size (mean ± SEM; n = 3; Mann–Whitney test) in PN-GSCs silenced for ITGA6 . Micrographs from representative fields of gliomaspheres (scale bar = 100 µm). ( D ) Self-renewal capacity (mean ± SEM; n = 4; unpaired t -test) and sphere size (mean ± SEM; n = 4; Mann–Whitney test) in MES-GSCs silenced for ITGA6 . The number of independent experiments— n , the number of gliomaspheres scored for each condition—N. The values specified within the bar plot indicate the mean relative self-renewal capacity. ( E ) Transcript levels of ITGA6 and NES detected by means of qPCR in shITGA6 PN-GSCs and MES-GSCs (mean ± SEM; n = 3; unpaired t -test). ( F ) Relative transcript amount of ALDH1A3 , a specific MES stem cell marker, in shITGA6 MES-GSCs (mean ± SEM; n = 3; unpaired t -test). *** p < 0.001; **** p < 0.0001.

Article Snippet: Non-targeting shRNA construct (shCTRL; source clone ID: RHS4348) and shITGA6 plasmid mapping against ITGA6 exon 15 (target sequence: AGGATATTGCTTTAGAAAT; source clone ID: V3LHS_326014) were purchased from Thermo-Scientific.

Techniques: Western Blot, shRNA, MANN-WHITNEY, Marker